A61M 60/143
Inside the coronary sinus
Official title: inside the coronary sinus, e.g. for pressure-controlled intermittent coronary sinus occlusion
A61M60/143 (Inside the coronary sinus) appears on 40 US grants and 44 published applications in this corpus.
Search patents in A61M- Granted patents
- 40
- Published applications
- 44
- Assignees
- 18
- Inventors
- 33
- Latest grant
- 14 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 2 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 4 |
| 2011 | 0 | 5 |
| 2012 | 4 | 8 |
| 2013 | 5 | 6 |
| 2014 | 6 | 1 |
| 2015 | 1 | 0 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 3 | 3 |
| 2021 | 0 | 0 |
| 2022 | 3 | 1 |
| 2023 | 2 | 2 |
| 2024 | 1 | 5 |
By publication year. Applications have been published since 2001.
Recent patents
- Treating heart tissue14 May 2024US 11,980,370 B2Miracor Medical SA
- Method and device for the intermittent occlusion of the coronary sinus8 Aug 2023US 11,717,302 B2Miracor Medical Systems GmbH
- Operating a vessel occlusion catheter30 May 2023US 11,660,096 B2Miracor Medical SA
- Treating heart tissue24 May 2022US 11,337,707 B2Miracor Medical SA
- Treating heart tissue5 Apr 2022US 11,291,455 B2Miracor Medical SA
- Fluid delivery based intravascular reperfusion therapy devices, systems, and methods26 Dec 2024US 2024/0424284 A1Koninklijke Philips N. V.
- Intravascular balloon reperfusion therapy devices, systems, and methods28 Nov 2024US 2024/0390567 A1Koninklijke Philips N. V.
- Treating heart tissue29 Aug 2024US 2024/0285283 A1Miracor Medical SA
- Valve stent for intravascular reperfusion therapy29 Aug 2024US 2024/0285407 A1Koninklijke Philips N. V.
- Systems, programs and methods for determining when to terminate a coronary sinus occlusion treatment4 Jul 2024US 2024/0215984 A1Miracor Medical SA
Most cited
By later US patents
- Coronary sinus retroperfusion apparatus for the treatment of myocardial ischemia295US 4,459,977 A1984
- Apparatus for providing coronary retroperfusion and methods of use161US 7,083,588 B1Medtronic Vascular, Inc. · 2006
- Minimally invasive ventricular assist technology and method117US 7,229,402 B2Cardiac Output Technologies, Inc. · 2007
- Coronary perfusion pump106US 4,804,358 AMedicorp Research Laboratories Corporation · 1989
- Heart analysis using pressure-controlled intermittent coronary sinus occlusion98US 4,969,470 ABoston Scientific Corporation · 1990